Heart attack symptoms: Five warning signs that may appear a month before you have one

HEART attack is a sudden and distressing event that requires immediate medical attention to prevent a potentially fatal complication. While symptoms tend to show up in the immediate run up to having a heart attack, they can also occur a month or even earlier - here are five warning signs.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news

Related Links:

Publication date: Available online 24 September 2019Source: Canadian Journal of DiabetesAuthor(s): Vincent C. WooAbstractAdults with type 2 diabetes mellitus can benefit from pharmacotherapies that lower their risk for cardiovascular disease. This review describes the salient findings from sodium-glucose cotransporter-2 (SGLT2) inhibitor cardiovascular outcome trials that serendipitously revealed the cardiorenal benefits of SGLT2 inhibitors in adults with type 2 diabetes mellitus who either have established cardiovascular disease or multiple cardiovascular risk factors. It also summarizes the findings from other phase 3 cl...
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research
In this study, 37.0% (n=452) of the population were admitted directly to Hospital de Braga and 63.0% (n=770) were transferred from other hospitals. Although timings (in min) until reperfusion were longer in interhospital transfer patients (symptom onset-first medical contact (median 76.5, IQR 40.3–150 vs. 91.0, IQR 50–180, p=0.002), first medical contact-reperfusion (median 87.5, IQR 69.0–114 vs. 145, IQR 115–199, p
Source: Revista Portuguesa de Cardiologia - Category: Cardiology Source Type: research
Publication date: Available online 12 December 2019Source: Revista Española de Cardiología (English Edition)Author(s): Emad Abu-Assi, José L. Bernal, Sergio Raposeiras-Roubin, Francisco J. Elola, Cristina Fernández Pérez, Andrés Íñiguez-RomoAbstractIntroduction and objectivesThere are few data on the safety of length of stay in uncomplicated ST-segment elevation myocardial infarction. We studied trends in hospital stay and the safety of short (≤ 3 days) vs long hospital stay in Spain.MethodsUsing data from the Minimum Basic Data Set, we identified patients with unc...
Source: Revista Espanola de Cardiologia - Category: Cardiology Source Type: research
Publication date: Available online 12 December 2019Source: IJC Heart &VasculatureAuthor(s): Anke C. Fender, Dobromir Dobrev
Source: IJC Heart and Vasculature - Category: Cardiology Source Type: research
ConclusionThe POPular CABG trial investigates whether adding ticagrelor to standard aspirin after CABG reduces the rate of SVG occlusion at one year.
Source: American Heart Journal - Category: Cardiology Source Type: research
DiscussionThe EMMY trial will test empagliflozin in patients with AMI regardless of their diabetic status. The EMMY trial may therefore underpin the concept of SGLT2 inhibition to improve cardiac remodeling, pre-and afterload reduction and cardiac metabolism regardless of its antidiabetic effects. Results will provide the rationale for the conduct of a cardiovascular outcome trial to test the effect of empagliflozin in patients with AMI.
Source: American Heart Journal - Category: Cardiology Source Type: research
Abstract Background: Evidence available suggests that periprocedural bradycardia negates the benefit of primary percutaneous coronary intervention (PPCI) and worsens the prognosis of patients with acute ST-elevation myocardial infarction (STEMI). Objective: To investigate the risk factors of periprocedural bradycardia during PPCI in patients with acute STEMI. Methods: We enrolled 2,536 acute STEMI patients who had PPCI from November 2007 to June 2018 in Beijing Anzhen Hospital, Capital Medical University. We divided all patients into two groups according to periprocedural bradycardia (preoperative heart ...
Source: Cardiology Research and Practice - Category: Cardiology Authors: Tags: Cardiol Res Pract Source Type: research
Publication date: Available online 12 December 2019Source: Biochimica et Biophysica Acta (BBA) - Molecular Cell ResearchAuthor(s): Akane Sakaguchi, Chihiro Nishiyama, Wataru KimuraAbstractHeart failure is a devastating disease that affects more than 26 million individuals worldwide and has a 5-year survival rate of less than 50%, with its development in part reflecting the inability of the adult mammalian heart to regenerate damaged myocardium. In contrast, certain vertebrate species including fish and amphibians, as well as neonatal mammals, are capable of complete cardiac regeneration after various types of myocardial in...
Source: Biochimica et Biophysica Acta (BBA) Molecular Cell Research - Category: Molecular Biology Source Type: research
CONCLUSIONS: Achieving stent optimisation on IVUS evaluation was associated with favourable outcomes in IVUS-guided, new-generation DES implantation for long coronary lesions including CTO. PMID: 31829943 [PubMed - as supplied by publisher]
Source: EuroIntervention - Category: Cardiovascular & Thoracic Surgery Tags: EuroIntervention Source Type: research
ConclusionThe level of MPs, especially CD31+CD42−EMPs and CD144+EMPs, had an increasing trend with the degree of CHD: NS
Source: Journal of Cardiovascular Translational Research - Category: Cardiology Source Type: research
More News: Cardiology | Health | Heart | Heart Attack | Warnings